Biotechnology Analysts Kluska & Duncan, along with Paige Nues, Family Empowerment Director of International Rett Syndrome Foundation, discuss how the Rett Syndrome landscape has changed since DAYBUE was approved on an Analyst/Industry conference call to be held on April 29 at 1 pm. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TSHA:
- Taysha Gene Therapies initiated with an Overweight at Piper Sandler
- Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Taysha Gene Therapies announces inducement grant under Nasdaq listing rule
- Taysha Gene Therapies price target raised to $7 from $5 at Chardan
- Taysha Gene Therapies On Edge: The High Stakes of TSHA-102’s Regulatory Approval Journey
